Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Details

Title
Author Correction: Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol
Author
Fu, Yue 1   VIAFID ORCID Logo  ; Estoppey, David 2   VIAFID ORCID Logo  ; Roggo Silvio 2 ; Pistorius Dominik 2 ; Fuchs Florian 2   VIAFID ORCID Logo  ; Studer, Christian 2 ; Ibrahim, Ashraf S 3 ; Aust, Thomas 2 ; Grandjean, Frederic 2   VIAFID ORCID Logo  ; Mihalic, Manuel 2 ; Memmert Klaus 2 ; Prindle Vivian 1   VIAFID ORCID Logo  ; Etienne, Richard 2 ; Riedl, Ralph 2 ; Schuierer Sven 2   VIAFID ORCID Logo  ; Weber, Eric 2 ; Hunziker Jürg 2 ; Petersen, Frank 2 ; Tao Jianshi 1   VIAFID ORCID Logo  ; Hoepfner Dominic 2   VIAFID ORCID Logo 

 Genomics Institute of the Novartis Research Foundation, San Diego, USA (GRID:grid.418185.1) (ISNI:0000 0004 0627 6737) 
 Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland (GRID:grid.419481.1) (ISNI:0000 0001 1515 9979) 
 The Lundquist Institute for Biomedical Innovations at Harbor-University of California at Los Angeles (UCLA) Medical Center, Torrance, USA (GRID:grid.239844.0) (ISNI:0000 0001 0157 6501); David Geffen School of Medicine at UCLA, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2429348941
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.